CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Cash and short-term investments (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $1.7B | +70.0% | 19.1% | 26.8% |
| Cash and short-term investments (Q2 2026) | $1.7B |
|---|---|
| YoY | +70.0% |
| 5-year CAGR | 19.1% |
| 10-year CAGR | 26.8% |
Cash and short-term investments
| Period | Cash | YoY |
|---|---|---|
| 2025 | $1.2B | 0.0% |
| 2024 | $1.2B | +83.1% |
| 2023 | $655M | −21.0% |
| 2022 | $829M | +33.0% |
| 2021 | $624M | +24.5% |
| 2020 | $501M | +87.1% |
| 2019 | $268M | +34.8% |
| 2018 | $199M | −30.4% |
| 2017 | $285M | +74.1% |
| 2016 | $164M | +46.9% |
| 2015 | $112M | +34.1% |
| 2014 | $83M | +3.7% |
| 2013 | $80M | +8.4% |
| 2012 | $74M | +51.0% |
| 2011 | $49M | −31.6% |
| 2010 | $72M | +180.3% |
| 2009 | $26M | −38.9% |
| 2008 | $42M | — |